Terapia Génica del Cáncer
TGC
Medical University of Vienna
Viena, AustriaPublikationen in Zusammenarbeit mit Forschern von Medical University of Vienna (2)
2021
-
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
Journal of Clinical Oncology, Vol. 39, Núm. 20, pp. 2304-2312
-
When and How To Use Endoscopic Tattooing in the Colon: An International Delphi Agreement
Clinical Gastroenterology and Hepatology, Vol. 19, Núm. 5, pp. 1038-1050